All Stories

  1. Species-specific components of the Helicobacter pylori Cag type IV secretion system
  2. A unique Helicobacter pylori strain to study gastric cancer development
  3. Taurine modulates host cell responses to Helicobacter pylori VacA toxin
  4. Correction: Subdomains of theHelicobacter pyloriCag T4SS outer membrane core complex exhibit structural independence
  5. Subdomains of theHelicobacter pyloriCag T4SS outer membrane core complex exhibit structural independence
  6. The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk
  7. Structural Analysis of Membrane-associated Forms of Helicobacter pylori VacA Toxin
  8. Role of the CagY antenna projection in Helicobacter pylori Cag type IV secretion system activity
  9. Identification of an Essential LolD-Like Protein in Helicobacter pylori
  10. A Positively Selected fur -R88H Mutation Enhances Helicobacter pylori Fitness in a High-Salt Environment and Alters Fur-Dependent Regulation of Gene Expression
  11. Regulation of Helicobacter pylori Urease and Acetone Carboxylase Genes by Nitric Oxide and the CrdRS Two-Component System
  12. Molecular architecture of bacterial type IV secretion systems
  13. Positive Selection of Mutations in the Helicobacter pylori katA 5′ Untranslated Region in a Mongolian Gerbil Model of Gastric Disease
  14. An infection-induced oxidation site regulates legumain processing and tumor growth
  15. Enhanced Fitness of a Helicobacter pylori babA Mutant in a Murine Model
  16. Tracking bacterial effector protein delivery into host cells
  17. Delineation of the pH-Responsive Regulon Controlled by the Helicobacter pylori ArsRS Two-Component System
  18. Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer
  19. Cryo-EM reveals species-specific components within the Helicobacter pylori Cag type IV secretion system core complex
  20. Cryo-EM reveals species-specific components within theHelicobacter pyloriCag type IV secretion system core complex
  21. The Helicobacter pylori Cag Type IV Secretion System
  22. Temporal Control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian Gerbil Model of Gastric Carcinogenesis
  23. Lipoprotein Processing and Sorting in Helicobacter pylori
  24. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants
  25. Bacterial Energetic Requirements for Helicobacter pylori Cag Type IV Secretion System-Dependent Alterations in Gastric Epithelial Cells
  26. Structure of a molecular machine in a bacterium that contributes to gastric cancer
  27. Effect of environmental salt concentration on the Helicobacter pylori exoproteome
  28. In Situ Molecular Architecture of the Helicobacter pylori Cag Type IV Secretion System
  29. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization
  30. Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells
  31. Helicobacter pylori VacA Targets Myeloid Cells in the Gastric Lamina Propria To Promote Peripherally Induced Regulatory T-Cell Differentiation and Persistent Infection
  32. Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability
  33. Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States
  34. Role of a Stem-Loop Structure in Helicobacter pylori cagA Transcript Stability
  35. Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression
  36. Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium
  37. Helicobacter pylori genetic diversification in the Mongolian gerbil model
  38. Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA
  39. High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins
  40. Genetic signatures for Helicobacter pylori strains of West African origin
  41. Helicobacter pylori Vacuolating Toxin and Gastric Cancer
  42. Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments
  43. Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy
  44. Magnetic Extraction of Acinetobacter baumannii Using Colistin-Functionalized γ-Fe2O3/Au Core/Shell Composite Nanoclusters
  45. Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis
  46. Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements
  47. Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration
  48. Epithelial Coculture and l-Lactate Promote Growth of Helicobacter cinaedi under H2-Free Aerobic Conditions
  49. Colistin-Functionalized Nanoparticles for the Rapid Capture of Acinetobacter baumannii
  50. Structural organization of membrane-inserted hexamers formed byHelicobacter pyloriVacA toxin
  51. A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain
  52. An Overview of Helicobacter pylori VacA Toxin Biology
  53. Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens
  54. Helicobacter pylori and stomach cancer
  55. Type IV secretion system in Helicobacter pylori
  56. Growth phase-dependent composition of the Helicobacter pylori exoproteome
  57. Supporting data for analysis of the Helicobacter pylori exoproteome
  58. Helicobacter pylori AdaptationIn Vivoin Response to a High-Salt Diet
  59. Alteration of theHelicobacter pylorimembrane proteome in response to changes in environmental salt concentration
  60. Regulation ofHelicobacter pyloriVirulence Within the Context of Iron Deficiency
  61. The Host Protein Calprotectin Modulates the Helicobacter pylori cag Type IV Secretion System via Zinc Sequestration
  62. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10
  63. Genes Required for Assembly of Pili Associated with the Helicobacter pylori cag Type IV Secretion System
  64. Helicobacter pylori outer membrane proteins
  65. Vacuolating Cytotoxin
  66. Human and Helicobacter pylori coevolution shapes the risk of gastric disease
  67. Control of gene expression in Helicobacter pylori using the Tet repressor
  68. Diet, microbial virulence, andHelicobacter pylori-induced gastric cancer
  69. Role of Connexin 43 in Helicobacter pylori VacA-Induced Cell Death
  70. Genome Sequences of Three hpAfrica2 Strains of Helicobacter pylori
  71. Impaired Autophagy, Defective T Cell Homeostasis, and a Wasting Syndrome in Mice with a T Cell-Specific Deletion of Vps34
  72. Flagellar Localization of a Helicobacter pylori Autotransporter Protein
  73. High Dietary Salt Intake Exacerbates Helicobacter pylori-Induced Gastric Carcinogenesis
  74. Functional Plasticity in the Type IV Secretion System of Helicobacter pylori
  75. Structure of the vacuolating toxin VacA from Helicobacter pylori
  76. Genetic analysis of Helicobacter pylori strains from East Asia
  77. Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori–infected children
  78. Structural Characterization of the Helicobacter Pylori VacA Toxin by Single Particle Em and X-Ray Crystallography
  79. Iron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans
  80. Analysis ofHelicobacter pylori cagAPromoter Elements Required for Salt-Induced Upregulation of CagA Expression
  81. The Intermediate Region of Helicobacter pylori VacA Is a Determinant of Toxin Potency in a Jurkat T Cell Assay
  82. Role ofHelicobacter pyloriCagL in modulating gastrin expression
  83. Non‐invasive Genotyping of Helicobacter pylori cagA, vacA, and hopQ from Asymptomatic Children
  84. J-Western Forms of Helicobacter pylori cagA Constitute a Distinct Phylogenetic Group with a Widespread Geographic Distribution
  85. Alterations in Helicobacter pylori Triggered by Contact with Gastric Epithelial Cells
  86. An RGD Helper Sequence in CagL of Helicobacter pylori Assists in Interactions with Integrins and Injection of CagA
  87. Helicobacter pylori type IV secretion system
  88. Analysis of cagA in Helicobacter pylori Strains from Colombian Populations with Contrasting Gastric Cancer Risk Reveals a Biomarker for Disease Severity
  89. β-Catenin and p120 Mediate PPARδ-Dependent Proliferation Induced by Helicobacter pylori in Human and Rodent Epithelia
  90. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism
  91. Helicobacter pylori VacA Induces Programmed Necrosis in Gastric Epithelial Cells
  92. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk
  93. Molecular Evolution of the Helicobacter pylori Vacuolating Toxin Gene vacA
  94. Reconstitution of Helicobacter pylori VacA toxin activity from p33 and p55 domains
  95. Analysis of Protein Expression Regulated by the Helicobacter pylori ArsRS Two-Component Signal Transduction System
  96. Analysis of a β-helical region in the p55 domain of Helicobacter pylori vacuolating toxin
  97. In Helicobacter pylori auto-inducer-2, but not LuxS/MccAB catalysed reverse transsulphuration, regulates motility through modulation of flagellar gene transcription
  98. Regulation of Gastric B Cell Recruitment Is Dependent on IL-17 Receptor A Signaling in a Model of Chronic Bacterial Infection
  99. Helicobacter pylori in Health and Disease
  100. Epidermal Growth Factor Receptor Activation Protects Gastric Epithelial Cells From Helicobacter pylori-Induced Apoptosis
  101. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer
  102. Structural Analysis of the DNA-binding Domain of the Helicobacter pylori Response Regulator ArsR
  103. Helicobacter pyloriHopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells
  104. Helicobacter pyloriand mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells
  105. Helicobacter pylori VacA Disrupts Apical Membrane-Cytoskeletal Interactions in Gastric Parietal Cells
  106. Helicobacter pylori VacA Subdomain Required for Intracellular Toxin Activity and Assembly of Functional Oligomeric Complexes
  107. β2 Integrin Mediates Entry of a Bacterial Toxin into T Lymphocytes
  108. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain
  109. Host response to Helicobacter pylori infection before initiation of the adaptive immune response
  110. Helicobacter pylori Vacuolating Cytotoxin Inhibits Activation-Induced Proliferation of Human T and B Lymphocyte Subsets
  111. l-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori
  112. Regulation of Helicobacter pylori cagA Expression in Response to Salt
  113. Soluble Proteins Produced by Probiotic Bacteria Regulate Intestinal Epithelial Cell Survival and Growth
  114. Serological Assays for Identification of Human Gastric Colonization by Helicobacter pylori Strains Expressing VacA m1 or m2
  115. Functional Analysis of Neutralizing Antibodies against Clostridium perfringens Epsilon-Toxin
  116. Role ofHelicobacter pyloriOuter Membrane Proteins in Gastroduodenal Disease
  117. Resistance of Primary Murine CD4+ T Cells to Helicobacter pylori Vacuolating Cytotoxin
  118. Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses
  119. Helicobacter pylori VacA Toxin Inhibits Human Immunodeficiency Virus Infection of Primary Human T Cells
  120. Random Mutagenesis of Helicobacter pylori vacA To Identify Amino Acids Essential for Vacuolating Cytotoxic Activity
  121. Quantitative Effect of luxS Gene Inactivation on the Fitness of Helicobacter pylori
  122. Protein-Protein Interactions among Helicobacter pylori Cag Proteins
  123. Multiple Chromosomal Loci for the babA Gene in Helicobacter pylori
  124. Requirement of Histidine Kinases HP0165 and HP1364 for Acid Resistance in Helicobacter pylori
  125. Mapping of a Domain Required for Protein-Protein Interactions and Inhibitory Activity of a Helicobacter pylori Dominant-Negative VacA Mutant Protein
  126. Helicobacter pylori vacuolating toxin
  127. Mimicry of a Host Anion Channel by a Helicobacter pylori Pore-Forming Toxin
  128. Analysis ofhopQalleles in East Asian and Western strains ofHelicobacter pylori
  129. The Oxysterol-binding Protein Homologue ORP1L Interacts with Rab7 and Alters Functional Properties of Late Endocytic Compartments
  130. High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy
  131. Genomic Comparison of cag Pathogenicity Island (PAI)-Positive and -Negative Helicobacter pylori Strains: Identification of Novel Markers for cag PAI-Positive Strains
  132. Functional Properties of the p33 and p55 Domains of the Helicobacter pylori Vacuolating Cytotoxin
  133. Helicobacter pylori VacA, a paradigm for toxin multifunctionality
  134. Growth Phase Regulation of flaA Expression in Helicobacter pylori Is luxS Dependent
  135. Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analysed by atomic force microscopy
  136. Heterogeneity among Helicobacter pylori Strains in Expression of the Outer Membrane Protein BabA
  137. Inhibition of primary human T cell proliferation byHelicobacter pylorivacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion
  138. Clustering and Redistribution of Late Endocytic Compartments in Response to Helicobacter pylori Vacuolating Toxin
  139. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells
  140. Interactions between p-33 and p-55 Domains of the Helicobacter pylori Vacuolating Cytotoxin (VacA)
  141. Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation
  142. Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH
  143. Expression of Helicobacter pylori Vacuolating Toxin in Escherichia coli
  144. Effects ofHelicobacter pylorion intracellular Ca2+signaling in normal human gastric mucous epithelial cells
  145. Essential Role of a GXXXG Motif for Membrane Channel Formation by Helicobacter pylori Vacuolating Toxin
  146. Recovery from lactacidosis-induced glial cell swelling with the aid of exogenous anion channels
  147. Two Different Families of hopQ Alleles in Helicobacter pylori
  148. Global analysis of Helicobacter pylori gene expression in human gastric mucosa
  149. PIKfyve Kinase and SKD1 AAA ATPase Define Distinct Endocytic Compartments. ONLY PIKfyve EXPRESSION INHIBITS THE CELL-VACUOLATING ACTIVITY OF HELICOBACTER PYLORI VacA TOXIN
  150. Genome-Wide Transcriptional Profiling in a Histidine Kinase Mutant of Helicobacter pylori Identifies Members of a Regulon
  151. Association of Helicobacter pylori Vacuolating Toxin (VacA) with Lipid Rafts
  152. Multiple Oligomeric States of the Helicobacter pylori Vacuolating Toxin Demonstrated by Cryo-electron Microscopy
  153. A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation
  154. In search of the Helicobacter pylori VacA mechanism of action
  155. Antigenic Diversity among Helicobacter pyloriVacuolating Toxins
  156. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease
  157. Amino-Terminal Hydrophobic Region ofHelicobacter pylori Vacuolating Cytotoxin (VacA) Mediates Transmembrane Protein Dimerization
  158. Carboxy-Terminal Proteolytic Processing ofHelicobacter pylori Vacuolating Toxin
  159. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells
  160. Intercellular Communication in Helicobacter pylori: luxS Is Essential for the Production of an Extracellular Signaling Molecule
  161. Cell Vacuolation Induced by the VacA Cytotoxin of Helicobacter pylori Is Regulated by the Rac1 GTPase
  162. A Dominant Negative Mutant of Helicobacter pyloriVacuolating Toxin (VacA) Inhibits VacA-induced Cell Vacuolation
  163. Vacuolating Cytotoxin ( vacA ) Alleles of Helicobacter pylori Comprise Two Geographically Widespread Types, m1 and m2, and Have Evolved Through Limited Recombination
  164. Helicobacter pylori Vacuolating Cytotoxin (VacA) Disorganizes the Cytoskeletal Architecture of Gastric Epithelial Cells
  165. Helicobacter pylori factors associated with disease
  166. Release ofHelicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium
  167. VacA fromHelicobacter pylori: a hexameric chloride channel
  168. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH
  169. Acid-induced expression of an LPS-associated gene inHelicobacter pylori
  170. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity
  171. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
  172. An intracellular target for Helicobacter pylori vacuolating toxin
  173. Acid-induced Dissociation of VacA, theHelicobacter pyloriVacuolating Cytotoxin, Reveals Its Pattern of Assembly
  174. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori
  175. High-level genetic diversity in the vapD chromosomal region of Helicobacter pylori.
  176. Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells.
  177. Density of Helicobacter pylori Infection In Vivo as Assessed by Quantitative Culture and Histology
  178. The gastrin-histamine sequence
  179. The vacuolating cytotoxin of Helicobacter pylori
  180. Helicobacter pylori and gastric acid: Biological and therapeutic implications
  181. Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori
  182. Analysis of Genetic Diversity in Cytotoxin-Producing and Non-Cytotoxin Producing Helicobacter pylori Strains
  183. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism
  184. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism
  185. Helicobacter pylori infection in japanese patients with adenocarcinoma of the stomach
  186. Potentiation of Helicobacter pylori Vacuolating Toxin Activity by Nicotine and Other Weak Bases
  187. Characterization of Hela cell vacuoles induced by Helicobacter pylori broth culture supernatant
  188. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.
  189. Helicobacter Pylori and Gastroduodenal Disease
  190. Evaluation of cytotoxic activity in fecal filtrates from patients with or enteritis
  191. Yersinia Enterocolitica
  192. The Pathobiology of Campylobacter Infections in Humans
  193. Pseudomonas paucimobilis Empyema After Cardiac Transplantation